Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardioangiologica 2013 April;61(2) > Minerva Cardioangiologica 2013 April;61(2):135-44

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  INTERVENTIONAL INNOVATION NOVEL THERAPIES AND THE BEST NEW DEVICE CONCEPT FOR 2013 

Minerva Cardioangiologica 2013 April;61(2):135-44

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Novel therapies and the best new device concepts for 2013 CAS techniques: the Mo.Ma® Proximal Occlusion System

Nikas D. N. 1, Torsello G. 2, Reimers B. 3

1 Cardiology Department, Ioannina University Hospital, Ioannina Medical School, Ioannina, Greece; 2 Department of Vascular and, Endovascular Surgery, Muenster University, Muenster, Germany; 3 Cardiology Department, Mirano Public Hospital, Mirano, Venice, Italy


PDF


Recently carotid artery stenting (CAS) was upgraded in the class of recommendation among other revascularization treatments for symptomatic patients with carotid artery disease. This makes CAS potentially available to a broader range of patients. Significant evolution in CAS materials and protection devices contributed towards this improvement. Particularly in the setting of symptomatic carotid stenosis the most important cerebral protection devices available today, are the proximal protection systems. Comparing to the distal, filter-type protection devices, proximal protection systems can offer complete cerebral protection by preventing embolization of debris in the brain even before lesion crossing. In the present manuscript, we are reviewing all data regarding the efficacy of the flow-blockage proximal protection system (Mo.Ma®, Medtronic, Minneapolis, MN, US) as well as its potential advantages and drawbacks.

top of page